Botswana Vaccine Maker Boosts Output to Secure Exports

Botswana Vaccine Institute Ltd. opened a new 200 million pula ($30 million) testing laboratory to boost vaccinations and make sure the country’s beef is safe for export to Europe.

The facility will help to “secure livestock trade” to markets around the world, President Ian Khama said today at an opening ceremony in the capital, Gaborone. It will more than double annual antigen production, allowing for sales to other countries in Africa, he said.

State-owned BVI, in partnership with animal-treatments maker Merial BV, produces vaccines for diseases including Foot and Mouth, according to the state-owned company’s website. Botswana exports about 9,700 metric tons of beef to the European Union a year and also ships meat to Asia, the Middle East and South America, Khama said.

To contact the reporter on this story: Jerry Bungu in Gaborone at jbungu@bloomberg.net

To contact the editor responsible for this story: Antony Sguazzin at asguazzin@bloomberg.net

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.